The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
A definitive model for predicting absolute risk of coronary heart disease (CHD) in male and female people with Type II diabetes is not yet available. This paper provides an equation for estimating the risk of new CHD events in people with Type II diabetes, based on data from 4540 U.K. Prospective Diabetes Study male and female patients. Unlike previously published risk equations, the model is diabetes-specific and incorporates glycaemia, systolic blood pressure and lipid levels as risk factors, in addition to age, sex, ethnic group, smoking status and time since diagnosis of diabetes. All variables included in the final model were statistically significant (P<0.001, except smoking for which P=0.0013) in likelihood ratio testing. This model provides the estimates of CHD risk required by current guidelines for the primary prevention of CHD in Type II diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The lower the CAD risk, the higher the chance of a false positive”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [248]
In the citing paper
“During the entire follow-up period, the rate of death among patients in the conventionaltherapy group was 50%, a finding that underscores the poor prognosis for such patients in the absence of intensive treatment.20”
From Effect of a multifactorial intervention on mortality in type 2 diabetes (2008) · cites this paper as [20]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Self-citationStratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Self-citationPrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Cited by
Items 801–900 of 1,000
Ambulatory Care Quality Measures for the 6 Aims From Administrative Data
Solberg, L., Engebretson, K. I., Sperl-Hillen, J., O'Connor, P., Hroscikoski, M., & Crain, A. (2006) · American Journal of Medical Quality · doi:10.1177/1062860606289071 · Cited by 14
“The reason for including CHD outcome measures in the DM table is that the United Kingdom Prospective Diabetes Study has demonstrated that people with diabetes have the same cardiac risks as those with a first heart attack.(12) Table 5 uses actual data to illustrate the results for the measures in Tables 1 and 2, using…”
BackgroundManaging diabetes: what to do about cardiovascular disease
Adler, A. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00127-x · Cited by 12
Self-citationZhou, J., Zhu, X.-R., Zhao, W., Yin, L., Li, H., Qi, L., & Yang, J. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0140 · Cited by 9
“Changes in the area under the receiver operating characteristic curve (AUC) were examined by integrating the presence or absence of PDR based on the traditional CV risk factors in the United Kingdom Prospective Diabetes Study (UKPDS) risk engine.(13,14) To determine the prediction of PDR to AO-CAD, a Cox proportional…”
Retracteddos Santos, A. L. T., Weiss, T., Duarte, C. K., Azevedo, M. J. D., & Zelmanovitz, T. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000500018 · Cited by 20
Ke, Z., Fan, L., Zhou, X., Sun, F., Zhu, Z., & Tong, W. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.11.013 · Cited by 8
Quantifying the Risk Continuum for Cardiovascular Death in Adults with Type 2 Diabetes
Williams, B. A., Blankenship, J. C., Voyce, S. J., Cordova, J. M., Gandhi, P., & Shetty, S. S. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.01.009 · Cited by 8
Qu, Y., Lee, J. J.-W., Zhuo, Y., Liu, S., Thomas, R., Owens, D. R., & Zee, B. C.-Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102687 · Cited by 8
“Risk equations for diabetes patients were also established, such as the Cardiac Risk Calculator from the UKPDS study [35].”
MethodMeddings, J. A., & McMahon, L. F. (2008) · Disease Management & Health Outcomes · doi:10.2165/00115677-200816040-00002 · Cited by 13
“using the UK Prospective Diabetes Study Group (UKPDS) risk So what can we learn from the cases of Mr Adam and Mr Bay to engine (see bottom of table V)[49,50] and each patient’s initial and keep pay for performance from transforming needy patients into follow-up visit data.”
BackgroundMethodChamnan, P., Simmons, R. K., Khaw, K.-T., Wareham, N. J., & Griffin, S. J. (2013) · Diabetologia · doi:10.1007/s00125-013-2854-8 · Cited by 9
“One example is the UK Prospective Diabetes Study (UKPDS) risk engine, which incorporates HbA1c and other risk factors to estimate cardiovascular risk in people with diabetes [18].”
BackgroundMetcalf, P., Wells, S. J., & Jackson, R. (2014) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2014.41003 · Cited by 8
“Ten-year coronary heart disease (CHD) risks were calculated using the Framingham [19] and UKPDS 56 [1] prediction equations, based on measurements of age, gender, smoking status, systolic blood pressure, total and HDL cholesterol, HbA1c (UKPDS only), known diagnosis of diabetes and time since diagnosis (UKPDS only).”
BackgroundMethodResultInfluentialWan, E. Y. F., Yu, E. Y. T., Chin, W. Y., Fung, C. S. C., Kwok, R. L. P., Chao, D. V. K., Chan, K. H., Hui, E. M., Tsui, W. W. S., Tan, K. C. B., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023070 · Cited by 8
“Cox regression is the method most commonly used in risk prediction models in the Framingham Heart Study(7) 8 and United Kingdom Prospective Diabetes Study .(25) 26 It allows us to estimate the risk of disease or death for an individual, given their prognostic variables.”
MethodDavis, W. A., Hellbusch, V., Hunter, M. L., Bruce, D. G., & Davis, T. M. E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051428 · Cited by 8
“1% [9] versus 34% and 25% of UKPDS male and female subjects, respectively [7]).”
BackgroundMacrovascular Risk Equations Based on the CANVAS Program
Willis, M. S., Asseburg, C., Slee, A. E., Nilsson, A., & Neslusan, C. A. (2021) · PharmacoEconomics · doi:10.1007/s40273-021-01001-0 · Cited by 8
Bandiera, C., Dotta-Celio, J., Locatelli, I., Nobre, D., Wuerzner, G., Pruijm, M. T., Lamine, F., Burnier, M., Zanchi, A., & Schneider, M. P. (2021) · JMIR Research Protocols · doi:10.2196/25966 · Cited by 8
Ho, J. C., Staimez, L. R., Narayan, K. M. V., Ohno-Machado, L., Simpson, R. L., & Hertzberg, V. (2022) · Computer Methods and Programs in Biomedicine Update · doi:10.1016/j.cmpbup.2022.100087 · Cited by 9
“We comprehensively evaluate the predictive performance of 13 diabetesspecific CVDR scores including 5 models, ARIC [12], DIAL [13], DMCx [14], HKDR [15–17], and UKPDS OM2 [18] that were not part of any previous validation study.”
MethodInfluentialHow many cardiovascular events can be prevented with optimal management of high-risk Canadians?
Grima, D. T., Leiter, L. A., Goodman, S. G., Attard, C. L., Chow, C.-M., & Langer, A. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70597-x · Cited by 8
Are Population-Based Diabetes Models Useful for Individual Risk Estimation?
Saver, B. G., Hargraves, J. L., & Mazor, K. M. (2011) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2011.04.110029 · Cited by 9
“Relative to the white male base case, the UKPDS model predicted a substantially lower MI risk for the Afro-Caribbean man, reflecting an observed finding of the UKPDS trial.(12) However, for the black man, the Diabetes PHD model predicted a similar MI risk.”
ResultThe relationship between hemoglobin a1c and chronic complications in diabetes mellitus
Timar, B., & Albai, O. (2012) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/v10255-012-0015-3 · Cited by 9
“Like other important trials, UKPDS proved that improving glycemic control is reducing not only the main microvascular complications of DM but also the incidence of MI or other causes of mortality [23, 24, 25].”
BackgroundAn economic model for the use of yoghurt in type 2 diabetes risk reduction in the UK
Lenoir‐Wijnkoop, I., Mahon, J., Claxton, L., Wooding, A., Prentice, A. M., & Finer, N. (2016) · BMC Nutrition · doi:10.1186/s40795-016-0115-1 · Cited by 8
“Heart failure and diabetic retinopathy – derived in Sheffield Diabetes model (SDM) from older UKPDS data [19];”
BackgroundCardiovascular risk prediction model for Omanis with type 2 diabetes
Alrawahi, A. H., Lee, P. J., Anqoudi, Z. A., Al-Rabaani, M., Al-Busaidi, A., Almahrouqi, F., & Al-Busaidi, A. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.09.012 · Cited by 8
Choi, Y., Yang, Y., Hwang, B., Lee, E. Y., Yoon, K., Chang, K., Jaffer, F. A., & Cho, J. (2020) · Clinical Cardiology · doi:10.1002/clc.23405 · Cited by 10
“The prescription rates of aspirin, beta-blockers, angiotensin-converting enzyme inhibitor/angiotensin receptor blockers, and statins did not differ between patients with and without obstructive CAD.”
MethodInfluentialDiabetes mellitus tipo 2 y enfermedad cardiovascular en España: una revisión descriptiva
Bueno, H., Hernáez, R., & Hernández, A. V. (2008) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(08)73555-6 · Cited by 12
Screening and risk stratification of patients with the metabolic syndrome and diabetes
Wong, N. D. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.2.181 · Cited by 8
Lee, S., Lee, K.-W., Kim, E. S., Park, Y. R., Kim, H., Park, S. A., Kang, M. J., Ahn, Y.-B., Yoon, K., Cha, B. Y., et al. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.6.488 · Cited by 9
Eckel, R. H., & Hokanson, J. E. (2016) · Circulation · doi:10.1161/circulationaha.116.021654 · Cited by 8
THE IMPORTANCE OF REACHING LIPID TARGETS: STATINS AND THE PREVENTION OF ATHEROSCLEROSIS
SCHWANDT, P. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10515.x · Cited by 9
Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP
Wens, J., Gerard, R., & Vandenberghe, H. (2010) · Primary care diabetes · doi:10.1016/j.pcd.2010.09.006 · Cited by 7
Coronary Artery Calcium Score directed risk stratification of patients with Type-2 diabetes mellitus
Nassar, M., Nso, N., Emmanuel, K. E., Alshamam, M. S., Munira, M. S., & Misra, A. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102503 · Cited by 9
Gami, A., Bisht, S., Satish, P., Blaha, M. J., & Patel, J. (2024) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2024.05.001 · Cited by 8
Zhang, L., Reshetnyak, E., Ringel, J. B., Pinheiro, L. C., Carson, A. P., Cummings, D. M., Durant, R. W., Malla, G., & Safford, M. M. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0380 · Cited by 11
Subclinical Cardiovascular Disease Assessment in Persons with Diabetes
Warraich, H. J., & Nasir, K. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0358-2 · Cited by 7
“While several scores have been developed including the United Kingdom Prospective Diabetes Study (UKPDS) score [12], the Munster Heart Study (PROCAM) score [13], and the Systematic Coronary Risk Evaluation (SCORE) score [14], the Framingham Risk Score (FRS) is the most commonly used global risk score [15].”
MethodBloomgarden, Z. T. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1644 · Cited by 9
“A total of 5,063 individuals with 736 CVD events in the UKPDS who were followed from the time of diabetes diagnosis were used to derive a " UKPDS Risk Engine " (14).”
MethodMalaha, A. K., Magné, J., Jarlan, L., Mansour, K., Ait--Ouatet, M., Galinat, S., Teissier, M. P., Lacroix, P., Désormais, I., & Aboyans, V. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.04.006 · Cited by 7
Farmer, A. A., Jones, L., Newhouse, N., Kenning, C., Williams, N., Yuan, C., Bartlett, Y. K., Plumpton, C., McSharry, J., Cholerton, R., et al. (2022) · JMIR Research Protocols · doi:10.2196/32918 · Cited by 8
Takahara, M., Katakami, N., Hayashino, Y., Nishimura, R., Suzuki, H., Shimano, H., Yoshioka, N., Tajima, N., & Yamasaki, Y. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01773-z · Cited by 8
Prediction of complications in health economic models of type 2 diabetes: a review of methods used
Li, X., Li, F., Wang, J., van Giessen, A., & Feenstra, T. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02045-8 · Cited by 8
Balducci, S., Haxhi, J., Vitale, M., Mattia, L., Sacchetti, M., Orlando, G., Cardelli, P., Iacobini, C., Bollanti, L., Conti, F., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3671 · Cited by 8
Tuncer, O., Du, Y., Baumert, J., Reitzle, L., & Heidemann, C. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01069-6 · Cited by 7
Shah, B. R., Austin, P. C., Ivers, N. M., Katz, A., Singer, A. G., Sirski, M., Thiruchelvam, D., & Tu, K. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.12.009 · Cited by 9
Burr, J. F., Shephard, R. J., & Riddell, M. C. (2012) · Europe PMC (PubMed Central) · Cited by 13
Standl, E. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112448876 · Cited by 7
Assessment of Cardiovascular Risk in Adults With Type 2 Diabetes and Metabolic Syndrome
Kim, C.-J., Kang, H.-S., Schlenk, E. A., & Chae, S.-M. (2015) · The diabetes educator · doi:10.1177/0145721715572154 · Cited by 5
“The Framingham risk score is a risk model used to assess the risk of CVD in the general population with or without diabetes,(21) while the UKPDS risk engine was developed to estimate the risk of CVD within 10 years for persons with T2DM.(22)”
MethodInfluentialPiñol, C., Roze, S., Valentine, W. J., & Evers, T. (2007) · Gaceta Sanitaria · doi:10.1157/13101034 · Cited by 10
Owolabi, M. O., Ipadeola, A., & Adeleye, J. O. (2010) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30656-8 · Cited by 9
Personal Health Systems for Diabetes Management, Early Diagnosis and Prevention
Zarkogianni, K., & Nikita, K. S. (2015) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-4666-8828-5.ch022 · Cited by 13
Κender, Ζ., Groener, J. B., Reismann, P., & Kopf, S. (2019) · Orvosi Hetilap · doi:10.1556/650.2019.31547 · Cited by 7
“A rizikókalkulátor a következő paraméterek figyelembevételével végzi a rizikóbecslést: életkor, nem, a cukorbetegség időtartama, HbA1c, szisztolés vérnyomás, pitvarfibrilláció megléte, etnikai hovatartozás, teljes szérumkoleszterin, HDL-koleszterin, dohányzás [22].”
BackgroundMousa, R., & Hammad, E. A. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1838900 · Cited by 7
“CVD risks used in the Markov model were estimated using the United Kingdom Prospective Diabetes Study (UKPDS) Risk Engine (version 2) [16].”
BackgroundMethodOrsi, E., Solini, A., Bonora, E., Vitale, M., Garofolo, M., Fondelli, C., Trevisan, R., Vedovato, M., Cavalot, F. L., Laviola, L., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01942-8 · Cited by 7
Leiria, L. F., Severo, M. D., Ledur, P. D. S., Becker, A. D., Aguiar, F. M., Massierer, D., de Freitas, V. C., Schaan, B. D., & Gus, M. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12231 · Cited by 11
Chang, Y., Lin, K.-C., Chang, D., Hsieh, C., & Yau-Jiunn, L. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.213 · Cited by 7
“In the UKPDS study, HDL-C was also identified as an important independent factor in predicting major CVD events in diabetic patients [13, 14].”
BackgroundCarotid Artery Disease in Diabetic Patients
Bosevski, M. (2014) · PRILOZI · doi:10.1515/prilozi-2015-0019 · Cited by 10
Tunis, S. L., Minshall, M. E., Charles, M. S., Pandya, B. J., & Baran, R. W. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802434874 · Cited by 7
Is aspirin effective in diabetic patients? Yes
Colwell, J. A. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01719.x · Cited by 8
Winter, L. J. M. B.-D., Cramer, M. J., Hoes, A. W., & Rutten, F. H. (2016) · Netherlands Heart Journal · doi:10.1007/s12471-016-0809-7 · Cited by 7
“Annually: self-monitoring skills Measure serum creatinine and estimate the glomerular filtration rate once a year Review the issue of erectile dysfunction in men annually Arrange repeat of structured eye surveillance annually If the person is considered not to be at high cardiovascular risk, estimate annually using th…”
Cardiovascular disease: primary prevention
Sharma, A. K., Dixon, S., & Claridge, T. (2017) · CRC Press eBooks · doi:10.1201/9781315376806-8 · Cited by 7
Liang, J., Pylypchuk, R. D., Tang, X., Shen, P., Liu, X., Chen, Y., Tan, J., Wu, J., Zhang, J., Lu, P., et al. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00795-9 · Cited by 7
“Prospective Diabetes Study model [16], ADVANCE model [17] from 20 countries, NZDCS equation and PREDICT-1° Diabetes equation [18, 19] from New Zealand and DIAL algorithm [20] from Sweden).”
MethodChin, S. O., Hwang, J. K., Rhee, S. Y., Chon, S., Hwang, Y., Oh, S., Ahn, K. J., Chung, H. Y., Woo, J., Kim, S.-W., et al. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.5.365 · Cited by 7
Yang, S., Xin, Z., Li, H., Zhu, Z., Zhu, Z., Shang, X., Huang, W., Zhang, L., He, M., Jonas, J. B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66979-z · Cited by 6
“We evaluated the incremental predictability of these states compared to the Age&Sex model and a spectrum of conventional algorithms for CMD prediction (FGCRS 65 , SCORE2 66 , AHA/ASCVD 67 , WHO-CVD 68 , FRS for T2D 69 , NZ-DCS 40 , UKPDS 41 and Wan ’ s model 42 ), where applicable.”
Kengne, A. P., Gouking, P., Wawo, E., Koki, G., Balti, E. V., Hakapoka, H., Dehayem, M. Y., Sobngwi, E., & Mbanya, J. C. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-014-0283-y · Cited by 6
“A striking fact, however, was the difference in estimates of coronary risk from the two equations [11, 12], which may raise concerns as to which one to recommend for use even for the intended purpose in the study context, in the absence of validation studies.”
BackgroundMethodHarle, C. A. (2007) · KiltHub Repository · doi:10.1184/r1/6471023 · Cited by 6
Wei, J.-H., Lee, M.-H., Lee, W., Chen, S., Almalki, O. M., Chen, J., Wu, C., & Lee, Y.-C. (2022) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2021.12.064 · Cited by 6
Motive perception pathways to the release of personal information to healthcare organizations
Soellner, M., & Koenigstorfer, J. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01986-4 · Cited by 6
“The prediction of future health-related outcomes, such as medical complications [11], treatment responses [12], patient readmissions [13], and patient mortality [14], increases efficiency and precision to the mutual benefit of patients and healthcare organizations.”
BackgroundOh, S.-H., Kang, J., & Kwon, J. (2024) · Journal of Medical Internet Research · doi:10.2196/51239 · Cited by 6
United States Pooled Cohort Cardiovascular Disease Risk Scores in Adults With Diabetes Mellitus
Zhao, Y., D’Agostino, R. B., Malik, S., Watson, K. E., Bertoni, A. G., Budoff, M. J., Cain, L., Correa, A., Folsom, A. R., Jacobs, D. R., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101448 · Cited by 7
Pokharel, D. R., Sigdel, M., Yadav, N. K., Sapkota, L. B., Sapkota, R. M., Khadka, D., Kafle, R., Nepal, S., & Choudhary, N. K. (2015) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.163642 · Cited by 6
Webb, D. R., Gray, L. J., Khunti, K., Campbell, S., Dallosso, H. M., & Davies, M. J. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.021 · Cited by 6
“[13] Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR.”
BackgroundAssessing renal risk in patients with type 2 diabetes
Thomas, M. C., & Groop, P. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.181 · Cited by 6
Glycated haemoglobin A1c measurement in stored whole blood sample is reliable for clinical use.
Ezenwaka, C. E., Seales, D., Surujlal, R., & Mathura, R. P. (2009) · PubMed · Cited by 9
Porras, L., Stafford, H. C., & Adams, N. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-71812-5_5 · Cited by 7
Predicting morbidity by local similarities in multi-scale patient trajectories
Carrasco-Ribelles, L. A., Pardo-Mas, J. R., Tortajada, S., Sáez, C., Valdivieso, B., & Garcia-Gomez, J. M. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103837 · Cited by 6
2021 Consensus Pathway of the Taiwan Society of Cardiology on Novel Therapy for Type 2 Diabetes
Chiang, C., Ueng, K., Chao, T., Lin, T., Wu, Y., Wang, K.-L., Sung, S., Yeh, H., Li, Y., Liu, P., et al. (2021) · JACC Asia · doi:10.1016/j.jacasi.2021.08.003 · Cited by 7
Valipour, M., Khalili, D., Solaymani–Dodaran, M., Motevalian, S. A., Khamseh, M. E., & Baradaran, H. R. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01224-2 · Cited by 6
“This model by using risk factors such as age, sex, race, smoking, BMI, blood pressure, total cholesterol, HDL cholesterol and HbA1c estimates the ten-year risk of CVD in patients with diabetes [17 ].”
MethodRossom, R. C., Crain, A. L., Waring, S. C., Sperl‐Hillen, J. M., Hooker, S. A., Miley, K. M., & O’Connor, P. J. (2023) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.22m14710 · Cited by 7
Takahara, M., Kaneto, H., Iida, O., Katakami, N., Sakamoto, F., Matsuoka, T., Ikeda, M., & Shimomura, I. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9951 · Cited by 6
Herath, H. M. M., Weerarathna, T. P., Dulanjalee, R. B. A. T., Jayawardana, M. R., Edirisingha, U. P., & Rathnayake, M. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/19356.8087 · Cited by 7
Generation of knowledge for clinical decision support
Matheny, M. E., & Lucila Ohno-machado, A. (2007) · Elsevier eBooks · doi:10.1016/b978-012369377-8/50011-8 · Cited by 6
Luque‐Ramírez, M., & de Burgoa, V. S. (2018) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2018.04.012 · Cited by 9
Use of the Burden of Diabetes Mellitus Score for Cardiovascular Disease Risk Assessment
Farjo, P. D., Barghouthi, N., Chima, N. R., Desai, A., Fang, W., Giordano, J., & Bianco, C. M. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.03.027 · Cited by 6
Zhuo, X., Cohen, C. M., Chen, J., Chodick, G., Alsumali, A., & Cook, J. R. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108086 · Cited by 8
Elosúa, R., & Salinas, A. M. (2011) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(11)15002-5 · Cited by 20
Wan, Q., Harris, M., Zwar, N. A., Campbell, T., Patel, A. A., Vagholkar, S., McKenzie, S. H., Walker, C. F., & Denney‐Wilson, E. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.11.016 · Cited by 6
Treatment of lipid disorders in patients with diabetes
Colhoun, H. M., & Betteridge, D. J. (2006) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-006-0024-8 · Cited by 6
“Triglycerides did not predict CHD independently of total:HDLC ratio [ 13 ].”
BackgroundSigal, R. J. (2005) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.10.2.57 · Cited by 6
Pradeepa, R., Nazir, A., & Mohan, V. (2012) · Heart Asia · doi:10.1136/heartasia-2011-010081 · Cited by 7
“87 It has been reported that the absolute risk of smoking is greater in diabetic, compared with non-diabetic subjects.”
BackgroundSpecial issue on emerging technologies for the management of diabetes mellitus
Zarkogianni, K., & Nikita, K. S. (2015) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-015-1422-4 · Cited by 9
Barrera-Guarderas, F., la Torre, K. D., Tapia, M. J. B., & Cabezas, C. (2020) · BJGP Open · doi:10.3399/bjgpopen20x101025 · Cited by 5
“Furthermore, the stabilisation of lipid profiles took into account atherogenicrisk calculation and, therefore, the start of statins(33) and the administration of acetylsalicylic acid (ASA) at low doses was based on the cardiovascular- risk score in people with diabetes.(34,35) Even though there is controversy surround…”
MethodPedersen, O. B. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00014.x · Cited by 5
Validation of QRISK2 (2014) in patients with diabetes
Hippisley‐Cox, J., Coupland, C. A. C., & Brindle, P. M. (2014) · Nottingham ePrints (University of Nottingham) · Cited by 5
FITCHETT, D. H. (2007) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(07)12011-6 · Cited by 5
A comparison of decision-maker perspectives for optimal cholesterol treatment
Mason, J. E., & Denton, B. T. (2012) · IBM Journal of Research and Development · doi:10.1147/jrd.2012.2201849 · Cited by 5
Chuang, J., Hsiao, O., Wu, P.-L., Chen, J., Liu, X., Cruz, H. D. L., Li, S.-H., & Chen, H. (2014) · Lecture notes in computer science · doi:10.1007/978-3-319-08416-9_7 · Cited by 5
“The most well-known risk engine is the UKPDS risk engine [4, 5], which predicts heart disease and stroke for type 2 diabetes patients.”
BackgroundIncidence of myocardial infarction in low-income urban residents of Mexico City
Jiménez-Corona, A., López‐Ridaura, R., & González‐Villalpando, C. (2009) · Salud Pública de México · doi:10.1590/s0036-36342009000600003 · Cited by 5
“25 It has been documented as well that the risk of CHD mortality due to diabetes in absence of cardiovascular disease is similar to that associated with a history of MI without diabetes.”
Ten-year prognostic value of coronary CT angiography in asymptomatic patients with type 2 diabetes
Hyun, J., Lee, P. H., Lee, J., Yang, Y., Kim, T. O., Kim, T. O., Kang, S.-J., Kim, J. K., Lee, S., & Lee, S. (2023) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2023.01.004 · Cited by 7
Zolezzi, M., Elhakim, A., Hejazi, T., Kattan, L., Mustafa, D. N., Aboelbaha, S., Homs, S., & Hamarneh, Y. N. A. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.02.001 · Cited by 5
Vimont, A., Béliard, S., Valéro, R., Leleu, H., & Durand‐Zaleski, I. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01105-x · Cited by 7
“67 based on validation studies of the following prognostic models: UKPDS calculator [21], the ADVANCE model [22], the DCS model [23], the Fremantle model [24] and the NDR model [25].”
MethodPark, H. W., Jo, S., Park, K. S., Lee, H., Jeon, Y., Park, S., Ann, S. H., Kim, Y., Choi, S. H., Kwon, W. J., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.07.036 · Cited by 5
An Italian Chart for Cardiovascular Risk Estimate Including High-Density Lipoprotein-Cholesterol
Menotti, A., & Lanti, M. (2008) · Disease Management & Health Outcomes · doi:10.2165/00115677-200816030-00005 · Cited by 6
Validation of the cardiovascular risk model developed for Omanis with type 2 diabetes
Alrawahi, A. H., & Lee, P. J. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.01.004 · Cited by 5
Szadkowska, A., Michalak, A., Chylińska-Frątczak, A., Baranowska‐Jaźwiecka, A., Koptas, M., Pietrzak, I., Hogendorf, A., Zmysłowska, A., Mlynarski, W. M., & Mianowska, B. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0098 · Cited by 5
Management of Diabetes Mellitus
Jenkins, A. J., SCOTT, E. S., Fulcher, J., Kilov, G., & Januszewski, A. S. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_7 · Cited by 6
Metadata
- Authors
- STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M.
- Affiliations
- University of Oxford (GB)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2001-12-01
- Volume
- 101
- Issue
- 6
- Pages
- 671
- ISSN
- 0143-5221 (ISSN-L)
- OpenAlex
- W2117191092
- Cited by
- 1,084
- References
- 51
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 10 · 2023: 33 · 2022: 44 · 2021: 60 · 2020: 46 · 2019: 42 · 2018: 47 · 2017: 42 · 2016: 39 · 2015: 60 · 2014: 66 · 2013: 68 · 2012: 59
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- coronary artery disease, type 2 diabetes, cardiovascular risk prediction, risk prediction model, glycemia, systolic blood pressure, serum lipids, primary prevention, smoking, sex differences
- MeSH terms
- Adult, Blood Pressure, Coronary Disease, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Lipids, Male, Middle Aged, Risk Factors, Smoking, Models, Statistical, Survival Rate, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.